MEDSIR MEDICA SCIENTIA INNOVATION RESEARCH Trademark

Trademark Overview


On Tuesday, September 21, 2021, a trademark application was filed for MEDSIR MEDICA SCIENTIA INNOVATION RESEARCH with the United States Patent and Trademark Office. The USPTO has given the MEDSIR MEDICA SCIENTIA INNOVATION RESEARCH trademark a serial number of 79324749. The federal status of this trademark filing is REGISTERED as of Tuesday, March 21, 2023. This trademark is owned by MEDICA SCIENTIA INNOVATION RESEARCH, S.L.. The MEDSIR MEDICA SCIENTIA INNOVATION RESEARCH trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Scientific and technological services, namely, scientific research, analysis and testing in the field of oncology; medical and pharmacological research services; consultancy relating to laboratory testing, namely, consultancy relating to scientific laboratory services; consultancy relating to research and development in the field of therapeutics; consultancy relating to pharmacology; consultancy relating to pharmaceutical research and development; development of pharmaceutical preparations and medicines; medical and scientific research, namely, conducting clinical trials for others; clinical studies, namely, clinical research in the field of oncology; evaluation of pharmaceutical products; scientific and medical research information regarding pharmaceutical products and clinical trials; biological research, clinical research in the field of oncology, and medical research; scientific research for medical purposes in the field of oncology; medical research; scientific research and develo...
medsir medica scientia innovation research

General Information


Serial Number79324749
Word MarkMEDSIR MEDICA SCIENTIA INNOVATION RESEARCH
Filing DateTuesday, September 21, 2021
Status700 - REGISTERED
Status DateTuesday, March 21, 2023
Registration Number7002593
Registration DateTuesday, March 21, 2023
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, January 3, 2023

Trademark Statements


Description of MarkThe mark consists of the stylized wording "MEDSIR" centered over the stylized wording "MEDICA SCIENTIA INNOVATION RESEARCH" with "SIR" in orange font and the rest of the wording in black font, and to the left of the wording is a design consisting of twelve circles creating five diagonal lines with the first and fifth lines each consisting of two separate gray circles, the second and fourth lines each consisting of three orange connected circles, and the third line consisting of two gray connected circles.
Pseudo MarkMEDICAL SIR MEDICAL SCIENTIA INNOVATION RESEARCH
Indication of Colors claimedThe color(s) orange, black and gray is/are claimed as a feature of the mark.
Disclaimer with Predetermined Text"INNOVATION RESEARCH"
Goods and ServicesScientific and technological services, namely, scientific research, analysis and testing in the field of oncology; medical and pharmacological research services; consultancy relating to laboratory testing, namely, consultancy relating to scientific laboratory services; consultancy relating to research and development in the field of therapeutics; consultancy relating to pharmacology; consultancy relating to pharmaceutical research and development; development of pharmaceutical preparations and medicines; medical and scientific research, namely, conducting clinical trials for others; clinical studies, namely, clinical research in the field of oncology; evaluation of pharmaceutical products; scientific and medical research information regarding pharmaceutical products and clinical trials; biological research, clinical research in the field of oncology, and medical research; scientific research for medical purposes in the field of oncology; medical research; scientific research and development; pharmaceutical drug development services; biomedical research services; pharmaceutical research services; laboratory research services relating to pharmaceuticals; medical research laboratory services; medical laboratory services; provision of information regarding results of clinical trials relating to pharmaceutical products

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, November 5, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameMEDICA SCIENTIA INNOVATION RESEARCH, S.L.
Party Type30 - Original Registrant
Legal Entity Type87 - NOT AVAILABLE
AddressES

Party NameMEDICA SCIENTIA INNOVATION RESEARCH, S.L.
Party Type20 - Owner at Publication
Legal Entity Type87 - NOT AVAILABLE
AddressES

Party NameMEDICA SCIENTIA INNOVATION RESEARCH, S.L.
Party Type10 - Original Applicant
Legal Entity Type87 - NOT AVAILABLE
AddressES

Trademark Events


Event DateEvent Description
Sunday, August 20, 2023FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, July 12, 2023GENERIC MADRID TRANSACTION SENT TO IB
Wednesday, July 12, 2023GENERIC MADRID TRANSACTION CREATED
Wednesday, June 21, 2023FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, March 21, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, March 21, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, January 3, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 3, 2023PUBLISHED FOR OPPOSITION
Wednesday, December 14, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, November 30, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 2, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, November 2, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, November 2, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, August 23, 2022REFUSAL PROCESSED BY IB
Friday, July 29, 2022NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, July 28, 2022REFUSAL PROCESSED BY MPU
Friday, July 8, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, July 7, 2022NON-FINAL ACTION WRITTEN
Thursday, June 23, 2022ASSIGNED TO EXAMINER
Tuesday, November 9, 2021APPLICATION FILING RECEIPT MAILED
Friday, November 5, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, November 4, 2021SN ASSIGNED FOR SECT 66A APPL FROM IB